Percutaneous microballoon compression for trigeminal neuralgia

Hong-bing Liu1, Yi Ma, Jian-jun Zou

  • 1Department of Neurosurgery, Qilu Hospital, Shandong University, Jinan 250012, China.

Abstract

Insights

Percutaneous microballoon compression (PMC) effectively treats trigeminal neuralgia, offering immediate pain relief for most patients. This minimally invasive procedure is a viable option, especially for elderly individuals.

Area of Science:

  • Neurosurgery
  • Pain Management

Background:

  • Trigeminal neuralgia is a debilitating condition requiring effective treatment.
  • Percutaneous microballoon compression (PMC) is an established therapeutic approach.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of PMC in a large cohort of trigeminal neuralgia patients.
  • To assess the long-term effectiveness and recurrence rates of PMC.

Main Methods:

  • 276 patients with trigeminal neuralgia underwent 290 PMC procedures between 2000 and 2003.
  • The Hakanson technique was used to place a needle into the foramen ovale under C-arm guidance.
  • A balloon catheter was advanced to Meckel's cave and inflated to compress the trigeminal ganglion.

Main Results:

  • Immediate pain relief was achieved in 252 out of 276 patients.
  • Mean follow-up was 18.7 months, with a recurrence rate of 5.1% (14 patients).
  • 12 of the 14 patients with recurrence were successfully re-treated with PMC.

Conclusions:

  • Percutaneous microballoon compression (PMC) is an effective and technically straightforward treatment for trigeminal neuralgia.
  • PMC demonstrates a high success rate and good long-term pain control.
  • This method is a recommended first-line treatment option, particularly for older patients.

Related Concept Videos